StonvexLoading…
StonvexStonvexStonvexCore line items from CSTL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $83.68M | $344.23M | $257.22M | $174.18M |
Operating Income | $-18.41M | $-42.81M | $-38.98M | $-32.18M |
Net Income | $-14.52M | $-24.16M | $-21.83M | $4.52M |
EPS (Diluted) | $-0.49 | $-0.83 | $-0.76 | $-0.74 |
Total Assets | $547.80M | $578.56M | $562.79M | $544.73M |
Total Liabilities | $86.39M | $107.68M | $95.74M | $89.35M |
Cash & Equivalents | $63.76M | $116.73M | $85.56M | $82.23M |
Free Cash Flow OCF − CapEx | $-34.58M | $28.33M | $8.58M | $782.00K |
Shares Outstanding | 30.30M | 29.69M | 29.16M | 28.98M |